Authors:
Barnabas, N
Shurafa, M
Van Dyke, DL
Wolman, SR
Clark, D
Worsham, MJ
Citation: N. Barnabas et al., Significance of p53 mutations in patients with chronic lymphocytic leukemia - A sequential study of 30 patients, CANCER, 91(2), 2001, pp. 285-293
Authors:
List, AF
Kopecky, KJ
Willman, CL
Head, DR
Persons, DL
Slovak, ML
Dorr, R
Karanes, C
Hynes, HE
Doroshow, JH
Shurafa, M
Appelbaum, FR
Citation: Af. List et al., Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study, BLOOD, 98(12), 2001, pp. 3212-3220
Authors:
Dhodapkar, MV
Jacobson, JL
Gertz, MA
Rivkin, SE
Roodman, GD
Tuscano, JM
Shurafa, M
Kyle, RA
Crowley, JJ
Barlogie, B
Citation: Mv. Dhodapkar et al., Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003), BLOOD, 98(1), 2001, pp. 41-48